Evaluation of hepcidin-25/erythroferrone ratio as a potential biomarker for iron utility and erythropoiesis responsiveness to erythropoiesis-stimulating therapy in comparison to immature erythrocyte/reticulocyte parameters in hemodialysis patients. - Bakr S; Salem KM; Rashed AM; Tantawy MEA; Elsary AY; Shamardl HA; Ezzat EM (Hematology, transfusion and cell therapy, 2024)